このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

TIVA Mobile Health Intervention for Family Caregivers (TIVA-Pilot)

2026年5月29日 更新者:Universidade do Porto

A Mobile Health Intervention for the Promotion of Mental Health in Family Caregivers: Protocol for a Pilot Study

This pilot study aims to evaluate the feasibility, usability, and preliminary effects of the TIVA mobile health intervention in promoting positive mental health among family caregivers of older adults. TIVA is a culturally adapted mobile application based on Lluch's Positive Mental Health model and designed to support caregivers through daily activities, motivational messages, relaxation strategies, and psychoeducational content over a four-week intervention period.

A pilot randomized controlled study with parallel allocation will be conducted involving family caregivers recruited in community and primary healthcare settings in Portugal. Participants will be allocated either to the TIVA intervention group or to a usual care control group. Outcomes will include positive mental health, caregiver burden, usability, satisfaction, adherence, and acceptability. Data will be collected at baseline, post-intervention, and follow-up.

This study intends to contribute to the development of accessible digital mental health strategies to support family caregivers and promote healthy ageing.

調査の概要

詳細な説明

This pilot randomized controlled trial aims to evaluate the feasibility, usability, acceptability, and preliminary effects of the TIVA mobile health intervention designed to promote positive mental health among family caregivers of older adults.

The TIVA intervention is a culturally adapted mobile application based on Lluch's Positive Mental Health model and derived from the Spanish "Cuidadoras Crónicos" program. The intervention includes daily psychoeducational content, motivational messages, relaxation exercises, and activities focused on emotional well-being, autonomy, interpersonal relationships, problem-solving, and self-care over a four-week period.

Family caregivers will be recruited from community and primary healthcare settings in Portugal. Eligible participants will be randomly allocated in a 1:1 ratio to either the intervention group (TIVA app plus usual care) or the control group (usual care only). Due to the nature of the intervention, participant blinding will not be feasible.

Data collection will occur at baseline (T0), immediately after the intervention period (T1), and at follow-up (T2). Outcomes will include positive mental health, caregiver burden, usability, satisfaction, adherence, and acceptability. Positive mental health will be assessed using the Positive Mental Health Questionnaire, and caregiver burden will be evaluated using the Zarit Burden Interview.

This study seeks to contribute to the development of accessible digital mental health strategies for family caregivers and to support healthy ageing policies and community-based care.

研究の種類

介入

入学 (推定)

80

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Unpaid family caregivers of a person with chronic illness, disability, or dependency.
  • Providing regular caregiving assistance for at least 4 months.
  • Living in Portugal.
  • Ability to read and understand Portuguese.
  • Ownership and use of a smartphone with internet access compatible with the TIVA mobile application.
  • Willingness to install and use the TIVA app for 4 weeks.
  • Ability to provide informed consent.

Exclusion Criteria:

  • Severe cognitive impairment.
  • difficulties preventing independent use of the application or completion of study assessments.
  • Severe psychiatric disorder or acute mental health crisis interfering with participation.
  • Participation in another structured caregiver support or psychological intervention during the study period.
  • Inability to use a smartphone independently.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:TIVA Intervention
Behavioral: TIVA Mobile Application
The intervention consists of the use of the TIVA mobile application over a four-week period. The application was culturally adapted for Portuguese family caregivers and is based on Lluch's Positive Mental Health model. The app includes daily activities, motivational messages, relaxation exercises, psychoeducational content, and self-reflection strategies aimed at promoting positive mental health and well-being among family caregivers of older adults.
介入なし:Usual Care
Active Comparator

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Positive Mental Health
時間枠:Baseline, post-intervention at 4 weeks, and 3-month follow-up

Positive Mental Health assessed using the Positive Mental Health Questionnaire (PMHQ). The PMHQ total score ranges from 39 to 156, with higher scores indicating better positive mental health, emotional well-being, autonomy, interpersonal relationship skills, self-control, and problem-solving ability. Lower scores indicate lower levels of positive mental health.

[Time Frame: Baseline, post-intervention at 4 weeks, and 3-month follow-up]

Baseline, post-intervention at 4 weeks, and 3-month follow-up

二次結果の測定

結果測定
メジャーの説明
時間枠
Caregiver Burden
時間枠:Baseline, post-intervention at 4 weeks, and 3-month follow-up
Caregiver burden assessed using the Zarit Burden Interview (ZBI). Total scores range from 0 to 88, with higher scores indicating higher levels of perceived caregiver burden, stress, and emotional overload associated with the caregiving role.
Baseline, post-intervention at 4 weeks, and 3-month follow-up

その他の成果指標

結果測定
メジャーの説明
時間枠
Usability of the TIVA Mobile Application
時間枠:Post-intervention at 4 weeks
Usability of the TIVA mobile application assessed using the System Usability Scale (SUS). SUS scores range from 0 to 100, with higher scores indicating greater usability, accessibility, and user satisfaction with the mobile application.
Post-intervention at 4 weeks
Satisfaction With the TIVA Mobile Application
時間枠:Post-intervention at 4 weeks.
User satisfaction assessed using a TIVA-specific satisfaction questionnaire based on Likert-scale items. Higher scores indicate greater satisfaction, usability, acceptability, and perceived usefulness of the TIVA mobile application.
Post-intervention at 4 weeks.
Adherence
時間枠:During the 4-week intervention period.
Adherence to the TIVA intervention assessed through in-app usage data, including frequency of logins, percentage of completed daily activities, and sustained participation throughout the 4-week intervention period. Higher adherence indicates greater engagement and continued use of the TIVA mobile application.
During the 4-week intervention period.
Acceptability of the TIVA Intervention
時間枠:Post-intervention at 4 weeks.
Acceptability of the TIVA intervention assessed through participant-reported perceptions of usefulness, relevance, satisfaction, and willingness to continue or recommend the intervention. Higher scores indicate greater acceptability and perceived value of the TIVA mobile application.
Post-intervention at 4 weeks.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Sandra MT Carreira, PhD Student、Instituto de Ciências Biomédicas Abel Salazar

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月1日

一次修了 (推定)

2027年3月1日

研究の完了 (推定)

2027年4月1日

試験登録日

最初に提出

2026年5月20日

QC基準を満たした最初の提出物

2026年5月29日

最初の投稿 (実際)

2026年6月1日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月1日

QC基準を満たした最後の更新が送信されました

2026年5月29日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be publicly shared due to privacy, ethical, and data protection considerations. Aggregated study results may be made available upon reasonable request and in accordance with institutional and ethical regulations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する